AKT1 and breast cancer: Finally, our overexpression assays showed that AKT1 upregulation restores the sensitivity of BC cells toward Doxorubicin treatment, while knockdown AKT1 can promote the DNA damage induced by Doxorubicin, suggesting that AKT1 is a key regulator of DNA damage.